Assessing Market Sentiment Towards Exelon (EXC) Stock

By Scott Lee • Saturday, May 04 10:08 • Permanent Link

After this morning's -1.3% drop to $37.41 per share, Exelon might just keep moving past its target price of $38.84. With an average analyst rating of hold, and target prices from $36.0 to $44.5, the stock's next move is anyone's guess.

Exelon's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.7%. The stock's short ratio is 2.73. The company's insiders own 0.13% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 87.3%. In conclusion, we believe there is mixed market sentiment regarding Exelon.

Institutions Invested in Exelon

Date Reported	Holder	Percentage	Shares	Value
2023-12-31	Wellington Management Group, LLP	10%	93,146,101	$3,484,595,624
2023-12-31	Vanguard Group Inc	9%	90,560,862	$3,387,881,833
2023-12-31	Blackrock Inc.	9%	90,115,271	$3,371,212,274
2023-12-31	State Street Corporation	6%	62,401,296	$2,334,432,473
2023-12-31	T. Rowe Price Investment Management, Inc.	3%	28,311,222	$1,059,122,810
2023-12-31	Geode Capital Management, LLC	2%	20,735,443	$775,712,919
2023-12-31	Massachusetts Financial Services Co.	2%	19,397,909	$725,675,772
2023-12-31	Morgan Stanley	2%	15,967,816	$597,355,994
2023-12-31	Legal & General Group PLC	2%	15,792,539	$590,798,881
2023-12-31	Deutsche Bank Aktiengesellschaft	2%	15,694,030	$587,113,659

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.